{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-21-004619","form_type":"8-K","ticker":"AGTX","cik":"0001603345","company_name":"Agentix Corp.","filed_at":"2021-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.764586+00:00","generated_at":"2026-06-30T05:25:12.427575+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Agentix corrects prior filing; enters merger to make Applied BioPharma wholly-owned sub","bullets":["Corrects May 27, 2021 8-K to clarify Applied BioPharma was not then a wholly-owned subsidiary.","Enters Merger Agreement (July 13, 2021) with AB Merger LLC to acquire Applied BioPharma for 1 share of common stock.","Articles of Merger executed July 14, 2021, expected to be filed with Nevada Secretary of State on July 15, 2021.","Upon consummation, Applied BioPharma will become a wholly-owned subsidiary of Agentix Corp."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-21-004619","json":"https://secwatch.observer/filing/0001477932-21-004619.json","markdown":"https://secwatch.observer/filing/0001477932-21-004619.md","text":"https://secwatch.observer/filing/0001477932-21-004619.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603345/000147793221004619/0001477932-21-004619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603345/000147793221004619/agtx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:25:12.427575+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}